Eosinophil differentiating activity in sera of patients with AIDS under recombinant IL-2 substitution

[1]  M. Ernst,et al.  Effects of systemicin vivo interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC) , 1986, Journal of Clinical Immunology.

[2]  M. Strath,et al.  Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures , 1985, The Journal of experimental medicine.

[3]  M. Vadas,et al.  Regulation of human granulocyte function by products derived from murine tumors. , 1985, Experimental hematology.

[4]  K. Welte,et al.  OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells. , 1985, Journal of immunology.

[5]  S. Rosenberg,et al.  In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. , 1985, Journal of immunology.

[6]  R. Mertelsmann,et al.  Human Interleukin-2 , 1984, Clinics in Immunology and Allergy.

[7]  A. Chang,et al.  The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma. , 1984, Journal of immunology.

[8]  S. Rosenberg,et al.  Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2 , 1984, The Journal of experimental medicine.

[9]  B. Rouse,et al.  Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. , 1984, Science.

[10]  B. Czarnetzki,et al.  The effect of eosinophil chemotactic factors on in vitro eosinopoiesis in the guinea pig , 1983, Blut.

[11]  B. Safai,et al.  Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and itsin vitro correction by interleukin 2 , 1983, Journal of Clinical Immunology.

[12]  J. Goedert,et al.  Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. , 1982, The Journal of infectious diseases.

[13]  S. Rosenberg,et al.  Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. , 1981, Cancer research.

[14]  R. Gallo,et al.  RC Gallo lymphocytes Human T-lymphocyte growth factor : regulation of growth and function of T , 1981 .

[15]  J. Goldberg,et al.  Myeloid differentiation of human blood mononuclear cells in liquid culture. , 1981, Blood.

[16]  D. Bass,et al.  Stimulation of eosinophil production in vitro by eosinophilopoietin and spleen-cell-derived eosinophil growth-stimulating factor , 1980 .

[17]  G. Johnson,et al.  Detection of a new type of mouse eosinophil colony by Luxol-fast-blue staining. , 1980, Experimental hematology.

[18]  T. Cockerell.  THE NEEDS OF SCIENTIFIC MEN. , 1905, Science.

[19]  M. Dietrich,et al.  Preliminary clinical observations with recombinant interleukin-2 in patients with AIDS or LAS , 2004, Blut.

[20]  J. Curran,et al.  Epidemiology of the acquired immunodeficiency syndrome , 1985 .

[21]  P. Volberding,et al.  Interferon and interleukin-2 therapy of Kaposi's sarcoma. , 1985, Advances in experimental medicine and biology.

[22]  J. Curran,et al.  Epidemiology of the acquired immunodeficiency syndrome (AIDS). , 1985, Epidemiologic reviews.

[23]  D. Bass,et al.  Stimulation of eosinophil production in vitro by eosinophilopoietin and spleen-cell-derived eosinophil growth-stimulating factor. , 1980, Blood.